Open Access
Issue
OCL
Volume 18, Number 4, Juillet-Août 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Première partie)
Page(s) 202 - 207
Section PUFA and Depression
DOI https://doi.org/10.1051/ocl.2011.0395
Published online 15 July 2011
  • Alloui A, Zimmermann K, Mamet J, et al. TREK-1, a K+ channel involved in polymodal pain perception. EMBO J 2006 ; 25 : 2368–2376. [CrossRef] [PubMed] [Google Scholar]
  • Blier P, de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999 ; 21 : 91S–98S. [PubMed] [Google Scholar]
  • Blier P. Possible neurobiological mechanisms underlying faster onset of antidepressant action. J Clin Psychiatry 2001 ; 62 (Suppl. 4): 7–11; discussion 37-40. [PubMed] [Google Scholar]
  • Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002 ; 22 : 821–834. [CrossRef] [Google Scholar]
  • Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002 ; 109 : 231–241. [CrossRef] [Google Scholar]
  • Dillon DG, Bogdan R, Fagerness J, Holmes AJ, Perlis RH, Pizzagalli DA. Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum Brain Map 2010 ; 31 : 210–221. [Google Scholar]
  • Ettaiche M, Fillacier K, Widmann C, Heurteaux C, Lazdunski M. Riluzole improves functional recovery after ischemia in the rat retina. Invest Ophthalmol Vis Sci 1999 ; 40 : 729–736. [PubMed] [Google Scholar]
  • Heurteaux C, Guy N, Laigle C, et al. TREK-1, a K(+) channel involved in neuroprotection and general anesthesia. EMBO J 2004 ; 23 : 2684–2695. [CrossRef] [PubMed] [Google Scholar]
  • Heurteaux C, Lucas G, Guy N, et al. Deletion of TREK-1, a background potassium channel, results in a depression-resistant phenotype. Nature Neurosci 2006 ; 9 : 1134–1141. [CrossRef] [PubMed] [Google Scholar]
  • Honore E. The neuronal background K2P channels: focus on TREK1. Nat Rev Neurosci 2007 ; 8 : 251–261. [CrossRef] [PubMed] [Google Scholar]
  • Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 ; 62 : 593–602. [CrossRef] [PubMed] [Google Scholar]
  • Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008 ; 455 : 894–902. [CrossRef] [PubMed] [Google Scholar]
  • Lang-Lazdunski L, Blondeau N, Jarretou G, Lazdunski M, Heurteaux C. Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J Vasc Surg 2003 ; 38 : 564–575. [CrossRef] [PubMed] [Google Scholar]
  • Lang-Lazdunski L, Heurteaux C, Vaillant N, Widmann C, Lazdunski M. Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 1999 ; 117 : 881–889. [CrossRef] [PubMed] [Google Scholar]
  • Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000 ; 19 : 1784–1793. [CrossRef] [PubMed] [Google Scholar]
  • Lesage F, Lazdunski M. Molecular and functional properties of two pore domain potassium channels. Am J Physiol 2000 ; 279 : 793–801. [Google Scholar]
  • Maingret F, Lauritzen I, Patel AJ, et al. TREK-1 is a heat-activated background K+ channel. EMBO J 2000 ; 19 : 2483–2491. [CrossRef] [PubMed] [Google Scholar]
  • Mazella J, Zsurger N, Navarro V, et al. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem 1998 ; 273 : 26273–26276. [CrossRef] [PubMed] [Google Scholar]
  • Mazella J, Petrault O, Lucas G, et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol 2010 ; 8 : e1000355. [CrossRef] [PubMed] [Google Scholar]
  • Munck Petersen C, Nielsen MS, Jacobsen C, et al. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J 1999 ; 18 : 595–604. [CrossRef] [PubMed] [Google Scholar]
  • Nestler EJ, Barrot M, DiLeone RJ, et al. Neurobiology of depression. Neuron 2002 ; 34 : 13–25. [CrossRef] [PubMed] [Google Scholar]
  • Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996 ; 16 : 2365–2372. [PubMed] [Google Scholar]
  • Nielsen MS, Madsen P, Christensen EI, et al. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 2001 ; 20 : 2180–2190. [CrossRef] [PubMed] [Google Scholar]
  • Noel J, Zimmermann K, Busserolles J, et al. The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception. EMBO J 2009 ; 28 : 1308–1318. [CrossRef] [PubMed] [Google Scholar]
  • Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004 ; 427 : 843–848. [CrossRef] [PubMed] [Google Scholar]
  • Perlis RH, Moorjani P, Fagerness J, et al. Pharmacogenetic Analysis of Genes Implicated in Rodent Models of Antidepressant Response: Association of TREK1 and Treatment Resistance in the STAR(*)D Study. Neuropsychopharmacology 2008 ; 33 : 2810–2819. [CrossRef] [PubMed] [Google Scholar]
  • Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003 ; 301 : 805–809. [CrossRef] [PubMed] [Google Scholar]
  • Westergaard UB, Sorensen ES, Hermey G, et al. Functional organization of the sortilin Vps10p domain. J Biol Chem 2004 ; 279 : 50221–50229. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.